“…In particular, it has been suggested that the manifestations and the course of the disease in some patients are modified by a superimposed autoimmune/inflammatory response, possibly driven by the changed immunogenicity of an abnormal MPZ protein, in keeping with the experimental observations of secondary autoimmunity and CIDP-like manifestations in P0 knockout mice [41,42]. In some patients, consistent features of an acute/subacute onset [20], rapidly progressive [43] or stepwise-fluctuating course [19,44,45], elevation of cerebrospinal fluid protein [19,20,22,[44][45][46], and response to immunotherapies [22,[44][45][46] were described, including cases with painful neuropathy. Other comorbidities potentially influencing the neuropathy expression, such as diabetes or B12 deficiency that are often associated with painful neuropathy, are not mentioned in the case studies.…”